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parathyroid gland, medullothyroid
gland, and pancreas f3 cells), l,25-dihy-
droxyvitamin D, and enzymes are in-
volved (3,4). Moreover, arteriosclerosis
and atherosclerosis are calcium-depen-
dent (3, 5). In IDD women, the signifi-
cant negative correlation between P1-
Ca and total cholesterol might be ac-
counted for by the internalization of
the calcium or even the cholesterol in
the artery wall at a younger age, de-
pending on whether cholesterol or cal-
cium increased in their plasma. Thus,
an increase in plasma cholesterol could
allow P1-Ca to penetrate into the ar-
tery intima, to form atherosclerotic
plaques in patients for whom athero-
sclerosis is very common and occurs
early (4). The Bogalusa Heart Study
(Framingham Junior survey) has just
provided additional proof that choles-
terol is one, if not the major, cause of
atherosclerosis (6). Could calcium be
the missing piece in this puzale of
atherosclerotic plaque formation?
Once again, biological results are
not the same for both sexes (2-4). The
epidemiologic, clinical, ergometric, and
therapeutic particularities of women
presenting with coronary insufficiency
have just been described (7). Our re-
sults raise questions that were not
resolved in that study, and suggest
that much work remains to be done.
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Problems in Standardization of
Digitalis-like Substance Assays by
Means of Competitive
Immunological Methods
To the Editor:
Although several studies have been
recently published concerning assay of
endogenous digoxin-like immunoreac-
tive substance(s) (Dus) in human body
fluids (1-6), and the putative endoge-
nous substance has been almost par-
tially purified and identified (7), there
is no accord on the nomenclature (ous,
DLF, OLF, Endoxin, Endaline, etc.)
and the best procedure(s) of sample
collection, storage, and assay. This
lack of standardization not only gener-
ates confusion, but also can be the
cause of discordant results and errone-
ous findings. The aim of this Letter is
to discuss some methodological points
of mis assay, adding personal contribu-
tions, in order to stimulate a more
general discussion among the groups
interested in studies concerning endog-
enous cardiac glycosides-like sub-
stances.
Sample preparation-Several au-
thors (8-13) used deproteinized (by
boiling) and concentrated plasma ex-
tracts for their studies in animals or
humans. We have recently used the
extraction with C18 reversed-phase
cartridges (Sep Pak, Waters Asso-
ciates) for the concentration and pre-
purification of biological samples (5,
14). This procedui-e seems preferable
when radioreceptor assay (RRA) and
(or) transmembrane ion-transport
studies are used with the ifiA for de-
tection of cardiac glycosides-like com-
pounds. In fact, by loading the sample
through the column, washing it with
40 mL of distilled water, and eluting
the plasma extracts with methanol it is
possible to remove the ions and pro-
teins and avoid this kind of interfer-
ences in RRA or transmembrane ion-
transport methods (14). This procedure
is rapid and the mean recovery was
82% (14).
On the other hand, we think that a
direct assay (without sample extrac-
tion and concentration) should be used
when plasma samples from newborns,
pregnant women, and patients with
renal or liver disease are assayed, be-
cause of their higher mis concentra-
tions in plasma in comparison with
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ed fromnewborns in the first day (Pool A) and
in the thirdand fourth days of extrauterine life
(Pool B)
The two pools were dispensed in several 1.mL
aliquotsarid stored at -20 ‘C until AlA.Only pool A
showed a signWucantlydecreased immunoreactlvity
during the study (r = 0.405, n = 50,
0.005< p <0.0001, y = 294.6 - 0.12x
normal adult subjects (2,3,5). In addi-
tion, urine samples from adults and
newborns have DLIS concentrations
four to six times higher than those in
plasma samples, so also in this case the
direct RIA seems preferable, as we
have previously reported (5, 15).
Sample storage-There are no data
in the literature on stability of DLIS
during storage. In our laboratory, two
pools (A and B) of urine from newborns
were stored in various 1-mL aliquots at
-20 #{176}Cand assayed by RIA for 17
months. Only pool A demonstrated a
significant decrease in immunoreactiv-
ity during this interval (Figure 1). This
discrepancy was probably ascribable to
the higher imprecision for assay of pool
B (CV about 22% vs 18%). The decay of
digoxin-like immunoreactivity was,
however, very small (about 1% per
month) and, also for pool A, a signifi-
cant decrease of mis was not detectable
before eight months of storage at
-20 #{176}C.Evidently DLIS can be validly
measured in urine samples stored for
some months at -20 #{176}C.Unfortunate-
ly, at present we have no definitive
data on the stability of mis in serum
(plasma) pools. We directly (i.e., with-
out extraction) assayed, during 10
months, a pool of plasma from blood
donors, but the very low DLIS concen-
tration, about 15 ng/L, did not permit a
significant statistical analysis because
of the high imprecision of the assay
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(CV >40%). Pooled plasma from new-
borns, from pregnant women, or from
patients with renal diseases, with
higher than normal DLIS concentra-
tions, could be used to test the stability
of digitalis-like immunoreactivity in
plasma.
Preparation of standard curve-Most
authors who have measured DLIS with
RIA or enzyme immunoassay methods
have used commercial kits and per-
formed the assay as suggested by the
manufacturers. In commercial kits for
digoxin assay, digoxin added to human
plasma (or serum) is generally used as
standard. We have previously demon-
strated (5, 11, 15) that, in normal plas-
ma, low but measurable amounts of
digoxin-like substance(s) are present.
Using a RIA kit with serum standards
for DLIS assay (SPAC Digoxin; Mallinck-
rodt, Dietzenbach, F.R.G.) we have
found that most (>70% in two different
assays) plasma samples (direct assay)
with mis concentrations within the
normal range (0-35 ngIL) have a
bound radioactivity higher than that of
the B0 standard. Therefore, it is impor-
tant to test for the presence of signifi-
cant amounts of DLIS in the serum-
basal standards used for the calibra-
tion curve. To avoid this kind of
interference we recommend the use of
buffer solutions containing standard
digoxin and human serum albumin
(11, 15) or low-molecular-mass-de-
prived human serum as standard for
calibration curves.
Immunological and biological activi-
ty-Because the chemical nature of
DUS is not yet known, it is not possible
to perform specific RIA assays for mis
by use of specific antisera against DLIS,
with DLIS as standard. The relatively
poor specificity of measurement of DLIS
with digoxin RIA kits makes it possi-
ble that substances with biological ac-
tivity similar to cardiac glycosides are
not detected by digoxin RIA methods.
For example, ouabain, a compound
that strongly inhibits Na/K ATPase
activity, does not significantly inter-
fere in our digoxin RIA system (11). On
the other hand, it is also possible that
several compounds interfering in the
RIA system do not share any biological
activity (12, 16, 17). However, we have
obtained a significant correlation (r =
0.72, n = 21, p <0.001) between DLIS
values obtained by RIA method or ra-
dioreceptor assay for 21 chromato-
graphed extracts (made by use of C15
Sep Pak cartridges) of plasma from
normal adults, pregnant women, and
neonates (14). Therefore, we think that
digoxin RIA or enzyme immunoassay
methods can be useful for DUB determi-
nation because they generally are
more sensitive, precise, and simple
than other techniques used to detect
endogenous cardiac-glycosides-like
compounds. However, immunological
methods should be used only as a
screening or preliminary test to detect
the possible presence of carcliac-glyco-
sides-like substances in human biologi-
cal fluids; for confirmation, more spe-
cific methods, used after chromato-
graphic purification, are required.
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Measurement of Stable Glycated
Hemoglobin
To the Editor:
In view of the concern regarding the
effect of the labile Schiff base adduct
(pre-Hb A1) on the true values for Hb
A1 as measured by cation-exchange
chromatography (1, 2), we report the
simple method used routinely in our
laboratory to remove pre-Hb A1.
Hb A1 was measured in one normal
subject and eight diabetic patients by
use of a medium-sized chromatograph-
ic column containing Bio-Rex 70 cat-
ion-exchange resin (3). Blood was col-
lected with EIYFA as anticoagulant,
and samples were variously treated as
below before the hemolysates were pre-
(a) Hb A1 was measured immediate-
ly after the blood was drawn.
(b) Whole anticoagulated blood (1.5
mL) was pipetted into 8.5 mL of isoton-
ic saline in a tube, mixed several times
with gentle inversion, then centrifuged
(10 mm, 3000 rpm) and the supernate
was discarded. A second 8.5-mL all-
quot of isotonic saline was added to the
sedimented erythrocytes, mixed by
gentle inversion until all the cells were
in suspension. The tube was then cen-
trifuged and the supernatant fluid was
again discarded. We then added 8.5 mL
of saline to the washed erythrocytes,
mixed well by gentle inversion until all
the cells were in suspension, then incu-
bated at 37 #{176}Cfor 6 h in a shaking
